Propanc Biopharma Insider Trades
NASDAQ: PPCBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Propanc Biopharma insider activity
No Propanc Biopharma insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Nathanielsz James Andrew (CEO/CFO) reporting a transaction in 5,928,000 shares on Aug 17, 2021. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PPCB's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
PPCB insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 17, 2021 | Kenyon Julian NormanChief Scientific Officer | Award | 3,420,000 | — | Form 4 |
| Aug 17, 2021 | Nathanielsz James AndrewCEO/CFO | Award | 2,800,000 | — | Form 4 |
| Aug 17, 2021 | Nathanielsz James AndrewCEO/CFO | Award | 5,928,000 | — | Form 4 |
| Feb 4, 2015 | Kenyon Julian NormanDirector | other | 17,654,470 | — | Form 4 |
| Feb 4, 2015 | Nathanielsz James AndrewCEO, CFO, Secretary, Treasurer | other | 33,259,350 | — | Form 4 |
| Jul 5, 2013 | Nathanielsz James AndrewChief Executive Officer | Sale | 55,000 | $4.98K | Form 4 |
| Jan 23, 2013 | Nathanielsz James AndrewChief Executive Officer | Sale | 15,000 | $3.00K | Form 4 |
| Dec 13, 2012 | Nathanielsz James AndrewChief Executive Officer | Sale | 5,500 | $1.10K | Form 4 |
| Sep 14, 2012 | Nathanielsz James AndrewChief Executive Officer | Sale | 5,000 | $1.00K | Form 4 |
| Sep 4, 2012 | Nathanielsz James AndrewChief Executive Officer | Sale | 250,000 | $50.00K | Form 4 |
| Aug 23, 2012 | Nathanielsz James AndrewChief Executive Officer | Buy | 250,000 | $50.00K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4